AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

DaVita Inc. (DVA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

155.06

-2.36 (-1.50%)

At close: Feb 18, 2025, 3:59 PM

155.05

-0.01%

After-hours: Feb 18, 2025, 04:10 PM EST

undefined% (undefined)

Bid	151.72
Market Cap	12.40B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	10.74
PE Ratio (ttm)	14.44
Forward PE	n/a
Analyst	Hold

Ask	155.99
Volume	1,419,289
Avg. Volume (20D)	719,422
Open	158.01
Previous Close	157.42
Day's Range	153.03 - 158.21
52-Week Range	119.42 - 179.60
Beta	undefined

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and manag...

[Show more]

Industry Medical - Care Facilities

Sector Healthcare

IPO Date Oct 31, 1995

Employees 76,000

Stock Exchange NYSE

Ticker Symbol DVA

Website https://www.davita.com

Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for DVA stock is "Hold." The 12-month stock price forecast is $169, which is an increase of 8.99% from the latest price.

Buy 20.00%

Hold 40.00%

Sell 20.00%

Stock Forecasts

Why Price Moved

4 days ago

-11.09%

DaVita shares are trading lower after the company ... Unlock content with Pro Subscription

6 days ago

+2.94%

DaVita shares are trading lower. The company reported Q4 financial results.

News

1 day ago · finbold.com

Here's why this Warren Buffett stock plunged 11% in a day

Shares of Davita Inc. (NYSE: DVA) plunged 11% on February 14, as the dialysis provider issued a weaker-than-expected 2025 earnings outlook, citing rising patient care costs, supply constraints, and on...

5 days ago · fool.com

Why DaVita Inc Stock Is Plummeting Today

Shares of DaVita Inc (DVA -11.09%) are trading lower on Friday. The company's stock lost 11.1% as of market close but lost as much as 15.2% earlier in the day.

5 days ago · marketwatch.com

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway pared its stake in the provider of kidney dialysis.

4 days ago · finbold.com

Here's why Warren Buffett dumped $31 million worth of this stock

Warren Buffett, the ‘Oracle of Omaha', managed to attain a roughly $142 billion net worth by consistently outperforming the markets. The Berkshire Hathaway (NYSE: BRK.B) chief executive officer (CEO) ...

4 days ago · cnbc.com

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement.

5 days ago · seekingalpha.com

DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

DaVita Inc. (NYSE:DVA ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Partici...

5 days ago · reuters.com

Berkshire sells some DaVita shares, cuts stake to 45%

Berkshire Hathaway said on Thursday night it sold 203,091 shares of DaVita , reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 bi...

6 days ago · zacks.com

DaVita HealthCare (DVA) Beats Q4 Earnings and Revenue Estimates

DaVita HealthCare (DVA) came out with quarterly earnings of $2.24 per share, beating the Zacks Consensus Estimate of $2.21 per share. This compares to earnings of $1.87 per share a year ago.

6 days ago · reuters.com

DaVita forecasts 2025 profit below estimates, shares plummet

Dialysis firm DaVita projected annual profit below estimates on Thursday due to rising patient care costs, sending its shares down 11% in after-hours trading.

6 days ago · zacks.com

DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?

Continued strength in RPT is likely to have boosted DaVita's top line in the fourth quarter despite supply challenges weighing on its performance.

Load More News